VIRX
T. Rowe Price Associates’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-81,136
| Closed | -$296K | – | 3018 |
|
|
2021
Q4 | $296K | Sell |
81,136
-987,676
| -92% | -$3.6M | ﹤0.01% | 2594 |
|
|
2021
Q3 | $8.57M | Buy |
+1,068,812
| New | +$8.57M | ﹤0.01% | 1439 |
|
|
2021
Q2 | – | Sell |
-510,000
| Closed | -$4.72M | – | 2951 |
|
|
2021
Q1 | $4.72M | Buy |
+510,000
| New | +$4.72M | ﹤0.01% | 1478 |
|
|
2015
Q3 | – | Sell |
-4,941,700
| Closed | -$14.9M | – | 2545 |
|
|
2015
Q2 | $14.9M | Sell |
4,941,700
-454,100
| -8% | -$1.37M | ﹤0.01% | 1234 |
|
|
2015
Q1 | $13.2M | Sell |
5,395,800
-274,200
| -5% | -$672K | ﹤0.01% | 1253 |
|
|
2014
Q4 | $14.5M | Sell |
5,670,000
-565,500
| -9% | -$1.44M | ﹤0.01% | 1223 |
|
|
2014
Q3 | $44.5M | Buy |
6,235,500
+2,722,100
| +77% | +$19.4M | 0.01% | 870 |
|
|
2014
Q2 | $22.9M | Buy |
3,513,400
+12,600
| +0.4% | +$82.2K | ﹤0.01% | 1079 |
|
|
2014
Q1 | $23.1M | Sell |
3,500,800
-150,500
| -4% | -$995K | 0.01% | 1068 |
|
|
2013
Q4 | $17.3M | Buy |
3,651,300
+800
| +0% | +$3.79K | ﹤0.01% | 1135 |
|
|
2013
Q3 | $18.1M | Buy |
3,650,500
+2,004,600
| +122% | +$9.94M | ﹤0.01% | 1111 |
|
|
2013
Q2 | $8.58M | Buy |
+1,645,900
| New | +$8.58M | ﹤0.01% | 1293 |
|